[ad_1]
ReNeuron Group PLC (LON: RENE) Michael Hunt met Andrew Scott of Proactive London after the announcement this morning of the appointment of a development director, Nick Adams, to help it strengthen the license agreements signed with the Chinese giant Fosun Pharma.
Hunt also discusses the recent publication of their preliminary results covering the 12-month period up to the end of March 2019.
One of the highlights of the year appeared in February, when they reported positive initial data from the mid-stage study of her treatment for retinitis pigmentosa.
Source link
